Skip to main content

ICAD To Participate At The Imagine AI Healthcare Investor Summit

NASHUA, N.H.

NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD) - Get iCAD, Inc. Report, a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey Stevens, President and incoming Chief Executive Officer, will present a corporate overview at Oppenheimer's Imagine AI + Healthcare Investor Summit being hosted by Oppenheimer in partnership with the Alliance for AI in Healthcare (AAIH).

Oppenheimer's Imagine AI + Healthcare Investor SummitDate:        Tuesday, December 7 th Time:        11:00 a.m. to 11:20 a.m. ET Registration Link

About iCAD, Inc. Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:Media Inquiries:Jessica Burns, iCAD +1-201-423-4492jburns@icadmed.com

Investor Relations:Brian Ritchie, LifeSci Advisors+ 1-212-915-2578britchie@lifesciadvisors.com